-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Abbott Laboratories, Lowers Price Target to $118

Benzinga·10/22/2026 13:55:47
Listen to the news
JP Morgan analyst Robbie Marcus maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $120 to $118.